Overbought Stock Signal: XTLB
Report Date: 03-25-2024
Symbol: XTLB - XTL Biopharmaceuticals Ltd.
Sector:
Industry:
Overbought Stock Signal: XTLB
XTL Biopharmaceuticals Ltd. (XTLB)
5 Badner Street
Ramat Gan, 5218102
Phone: 972 3 611 6600
Website: https://www.xtlbio.com
CEO: Mr. Shlomo Spokone Shalev
NASDAQ, Nasdaq Capital Market
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
daily stock signals, free trading signals, stock market trading signals, options trade signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228